Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matti L Gild

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 5, 2024
A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosisShejil Kumar, Matti L Gild, Michelle M McDonald, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|March 19, 2025
Pheochromocytoma in MEN2Matti L Gild, Kimchi Do, Venessa H M Tsang, et al.
Endocrine-Related Cancer|June 11, 2026
Functional Imaging in Hereditary Endocrine Neoplasms: Evolving Modalities and Clinical ImplicationsStephen Ludgate, Sarah C Brennan, James McNeil, et al.
Cancers|May 4, 2026
Correction: Nguyen et al. Prognostic Significance of Key Molecular Markers in Thyroid Cancer: A Systematic Literature Review and Meta-Analysis. <i>Cancers</i> 2025, <i>17</i>, 939Linh T T Nguyen, Emma K Thompson, Nazim Bhimani, et al.
Cancers|March 28, 2025
Prognostic Significance of Key Molecular Markers in Thyroid Cancer: A Systematic Literature Review and Meta-AnalysisLinh T T Nguyen, Emma K Thompson, Nazim Bhimani, et al.
Endocrinology, Diabetes & Metabolism Case Reports|May 28, 2024
Pulmonary BRAF-driven Langerhans cell histiocytosis following selpercatinib use in metastatic medullary thyroid cancerKatherine Wu, Shejil Kumar, Ed Hsiao, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 20, 2026
A new age of osteoanabolic therapy? A real-world, two-centre study comparing effects of romosozumab, teriparatide, and antiresorptive therapies for osteoporosisIndia Richardson-Thornton, Sarah C Brennan, Livia Liu, et al.
Endocrine Research|May 22, 2025
Validation of a Lenvatinib Assay: A Pilot StudyMonica Majumder, Lucy E Ding, Cameron Wood, et al.
Thyroid : Official Journal of the American Thyroid Association|June 15, 2022
Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral LymphadenopathyAlexander Papachristos, Kimchi Do, Venessa H Tsang, et al.
Head & Neck|March 15, 2024
Neoadjuvant therapy to improve resectability of advanced thyroid cancer: A real-world experienceMarika Russell, Matti L Gild, Lori J Wirth, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 5, 2024
A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosisShejil Kumar, Matti L Gild, Michelle M McDonald, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|March 19, 2025
Pheochromocytoma in MEN2Matti L Gild, Kimchi Do, Venessa H M Tsang, et al.
Endocrine-Related Cancer|June 11, 2026
Functional Imaging in Hereditary Endocrine Neoplasms: Evolving Modalities and Clinical ImplicationsStephen Ludgate, Sarah C Brennan, James McNeil, et al.
Cancers|May 4, 2026
Correction: Nguyen et al. Prognostic Significance of Key Molecular Markers in Thyroid Cancer: A Systematic Literature Review and Meta-Analysis. <i>Cancers</i> 2025, <i>17</i>, 939Linh T T Nguyen, Emma K Thompson, Nazim Bhimani, et al.
Cancers|March 28, 2025
Prognostic Significance of Key Molecular Markers in Thyroid Cancer: A Systematic Literature Review and Meta-AnalysisLinh T T Nguyen, Emma K Thompson, Nazim Bhimani, et al.
Endocrinology, Diabetes & Metabolism Case Reports|May 28, 2024
Pulmonary BRAF-driven Langerhans cell histiocytosis following selpercatinib use in metastatic medullary thyroid cancerKatherine Wu, Shejil Kumar, Ed Hsiao, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 20, 2026
A new age of osteoanabolic therapy? A real-world, two-centre study comparing effects of romosozumab, teriparatide, and antiresorptive therapies for osteoporosisIndia Richardson-Thornton, Sarah C Brennan, Livia Liu, et al.
Endocrine Research|May 22, 2025
Validation of a Lenvatinib Assay: A Pilot StudyMonica Majumder, Lucy E Ding, Cameron Wood, et al.
Thyroid : Official Journal of the American Thyroid Association|June 15, 2022
Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral LymphadenopathyAlexander Papachristos, Kimchi Do, Venessa H Tsang, et al.
Head & Neck|March 15, 2024
Neoadjuvant therapy to improve resectability of advanced thyroid cancer: A real-world experienceMarika Russell, Matti L Gild, Lori J Wirth, et al.
Pageof 5